The Discounted Cash Flow (DCF) valuation of Thalys Medical Technology Group Inc (603716.SS) is 1.92 CNY. With the latest stock price at 12.54 CNY, the upside of Thalys Medical Technology Group Inc based on DCF is -84.7%.
Based on the latest price of 12.54 CNY and our DCF valuation, Thalys Medical Technology Group Inc (603716.SS) is a sell. selling 603716.SS stocks now will result in a potential gain of 84.7%.
| Range | Selected | |
| WACC / Discount Rate | 8.0% - 11.1% | 9.6% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | 0.51 - 5.70 | 1.92 |
| Upside | -95.9% - -54.6% | -84.7% |